Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Hyperaldosteronism × Radiofrequency Ablation × Endocrine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Thyroid Cancer, Papillary 2 Adrenocortical Adenoma 2 Thyroid Nodule 1 Thyroid Neoplasms 1 Pancreatic Neuroendocrine Tumors, WHO Grade I-II 1 Neuroendocrine Tumors 1 Neoplastic Cells, Circulating 1 Hyperaldosteronism 1 Carcinoma, Hepatocellular 1 Adrenal Gland Neoplasms 1

Interventions

Staining and Labeling 1 Radiofrequency Ablation 1 Observation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02030587 2017-04-25

LARFA

Chinese University of Hong Kong

Phase NA Unknown

Hyperaldosteronism, Adrenocortical Adenoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡